Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)

NCT05621252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: PLN-74809
DRUG: Placebo

Sponsor

Pliant Therapeutics, Inc.